Archean Chemical Industries Ltd
Archean Chemical Industries Limited is India's largest exporter of bromine and industrial salt in Fiscal 2021. The company is the leading specialty marine chemical manufacturer in India and is focused on producing and exporting bromine, industrial salt, and sulphate of potash to customers around the world.[1]
- Market Cap ₹ 6,485 Cr.
- Current Price ₹ 525
- High / Low ₹ 728 / 483
- Stock P/E 42.0
- Book Value ₹ 162
- Dividend Yield 0.48 %
- ROCE 10.6 %
- ROE 7.96 %
- Face Value ₹ 2.00
Pros
- Company has been maintaining a healthy dividend payout of 17.2%
- Company's working capital requirements have reduced from 59.5 days to 31.8 days
Cons
- The company has delivered a poor sales growth of 7.05% over past five years.
- Company has a low return on equity of 12.7% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| 439 | 566 | 608 | 741 | 1,130 | 1,441 | 1,330 | 1,014 | 1,042 | |
| 356 | 497 | 460 | 478 | 663 | 807 | 865 | 691 | 781 | |
| Operating Profit | 83 | 69 | 148 | 262 | 467 | 634 | 464 | 323 | 261 |
| OPM % | 19% | 12% | 24% | 35% | 41% | 44% | 35% | 32% | 25% |
| 6 | 121 | 8 | 14 | 13 | 44 | 47 | 9 | 47 | |
| Interest | 102 | 114 | 122 | 130 | 162 | 97 | 10 | 9 | 18 |
| Depreciation | 73 | 47 | 52 | 55 | 67 | 69 | 70 | 73 | 80 |
| Profit before tax | -85 | 29 | -17 | 90 | 251 | 513 | 431 | 250 | 210 |
| Tax % | -7% | -41% | 105% | 26% | 25% | 25% | 25% | 26% | 27% |
| -79 | 41 | -36 | 67 | 189 | 384 | 322 | 185 | 154 | |
| EPS in Rs | -79.16 | 21.31 | -18.50 | 34.56 | 19.58 | 31.18 | 26.12 | 14.98 | 12.50 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 8% | 11% | 20% | 20% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 7% |
| 3 Years: | -10% |
| TTM: | 3% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 19% |
| 3 Years: | -26% |
| TTM: | -28% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | -1% |
| 1 Year: | -16% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 20% |
| 3 Years: | 13% |
| Last Year: | 8% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 10 | 19 | 19 | 19 | 19 | 25 | 25 | 25 | 25 |
| Reserves | -38 | 24 | -12 | 55 | 243 | 1,408 | 1,682 | 1,855 | 1,973 |
| 968 | 754 | 854 | 904 | 897 | 69 | 39 | 108 | 322 | |
| 316 | 439 | 568 | 457 | 372 | 254 | 246 | 261 | 252 | |
| Total Liabilities | 1,256 | 1,237 | 1,430 | 1,434 | 1,532 | 1,756 | 1,991 | 2,249 | 2,571 |
| 940 | 914 | 882 | 1,042 | 1,086 | 1,097 | 1,086 | 1,071 | 1,067 | |
| CWIP | 0 | 9 | 193 | 19 | 17 | 33 | 21 | 28 | 53 |
| Investments | 0 | 0 | 47 | 41 | 16 | 215 | 347 | 350 | 268 |
| 316 | 314 | 308 | 332 | 412 | 410 | 537 | 800 | 1,184 | |
| Total Assets | 1,256 | 1,237 | 1,430 | 1,434 | 1,532 | 1,756 | 1,991 | 2,249 | 2,571 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| 39 | 312 | 148 | 119 | 327 | 498 | 389 | 169 | 189 | |
| 0 | -25 | -197 | -2 | -128 | -288 | -260 | -196 | -339 | |
| -87 | -252 | 26 | -110 | -224 | -212 | -91 | 19 | 138 | |
| Net Cash Flow | -48 | 35 | -23 | 7 | -24 | -2 | 39 | -8 | -13 |
| Free Cash Flow | 33 | 281 | -4 | 109 | 231 | 402 | 345 | 75 | 128 |
| CFO/OP | 47% | 456% | 100% | 45% | 70% | 82% | 107% | 70% | 95% |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 22 | 43 | 27 | 34 | 49 | 30 | 43 | 62 | 48 |
| Inventory Days | 830 | 238 | 532 | ||||||
| Days Payable | 1,035 | 398 | 415 | ||||||
| Cash Conversion Cycle | -183 | -116 | 27 | 34 | 49 | 30 | 160 | 62 | 48 |
| Working Capital Days | -70 | 0 | -38 | 22 | 50 | 41 | 54 | 92 | 32 |
| ROCE % | 3% | 13% | 24% | 39% | 46% | 26% | 16% | 11% |
Insights
In beta| Mar 2020 | Mar 2021 | Mar 2022 | Dec 2025 | |
|---|---|---|---|---|
| Installed Capacity - Industrial Salt MTPA |
|
|||
| Sales Volume - Bromine MT |
||||
| Sales Volume - Industrial Salt MT |
||||
| Installed Capacity - Bromine MTPA |
||||
| Installed Capacity - SOP MTPA |
||||
| Production Volume - Bromine MT |
||||
Extracted by Screener AI
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Acquisition
8h - Archean Chemical to invest up to Rs.170 crore in Acume Chemicals rights issue within one month.
-
Compliances-Reg.24(A)-Annual Secretarial Compliance
1d - Annual Secretarial Compliance Report for FY ended March 31, 2026, notes delayed disclosures and prior Rs.35,000 penalty.
-
Compliances-Reg.24(A)-Annual Secretarial Compliance
1d - FY2026 secretarial compliance report filed; noted delay in Regulation 30 intimations.
- Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011. 26 May
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
25 May - Archean Chemical will attend 360 ONE Capital Trinity India 2026 investor meetings on May 28, 2026.
Annual reports
Concalls
-
May 2026Transcript PPT
-
Feb 2026Transcript PPT REC
-
Nov 2025Transcript PPT REC
-
Aug 2025Transcript PPT REC
-
May 2025Transcript PPT REC
-
Feb 2025Transcript PPT
-
Nov 2024Transcript PPT
-
Aug 2024TranscriptPPTREC
-
Aug 2024TranscriptPPT REC
-
May 2024Transcript PPT REC
-
Feb 2024Transcript PPT REC
-
Nov 2023Transcript PPT REC
-
Aug 2023Transcript PPT
-
May 2023TranscriptPPT
-
May 2023Transcript PPT REC
-
Feb 2023TranscriptPPTREC
-
Feb 2023Transcript PPT
Business Area[1]
The company is specialty marine chemicals company engaged in the production of Industrial Salt, Bromine and Sulphate of Potash (SOP) from natural sea brine resources. The company operates an integrated business model supported by strategic brine reserves and captive port infrastructure, while also expanding into bromine derivatives, specialty chemicals, energy storage and semiconductor materials to strengthen its long-term growth portfolio.